ETORICOXIB DEXCEL 60 MG
Country: Israel
Language: English
Source: Ministry of Health
Patient Information leaflet
(PIL)
19-11-2020
Public Assessment Report
(PAR)
01-10-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ETORICOXIB
Available from:
DEXCEL LTD, ISRAEL
ATC code:
M01AH05
Pharmaceutical form:
TABLETS
Composition:
ETORICOXIB 60 MG
Administration route:
PER OS
Prescription type:
Required
Manufactured by:
DEXCEL LTD, ISRAEL
Therapeutic area:
ETORICOXIB
Therapeutic indications:
For the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis.
Authorization date:
2023-02-28
